TMTakayasu Mori

Takayasu Mori

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Takayasu Mori has a total of 174 co-authors. Here are the top co-authors by number of shared publications:

  • Shinichi Uchida

    Department of Nephrology, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo

    24 shared publications
  • Eisei Sohara

    Department of Nephrology, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo, Tokyo, Japan

    14 shared publications
  • Eisei Sohara

    Department of Nephrology Graduate School of Medical and Dental Sciences, Institute of Science Tokyo Tokyo Japan

    11 shared publications
  • Fumiaki Ando

    Department of Nephrology, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo, Bunkyo, Japan

    11 shared publications
  • Koichiro Susa

    Department of Nephrology, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo, Tokyo, Japan

    11 shared publications
  • Shintaro Mandai

    Department of Nephrology, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo, Tokyo, Japan

    11 shared publications

Latest Publications

  • Open Access

    Dietary Fiber Attenuates the Association between Protein Intake and BUN in Patients with CKD

    by Nobuhisa Morimoto, Tamami Fujiki, Shintaro Mandai, Fumiaki Ando, Takayasu Mori, Koichiro Susa, Shotaro Naito, Eisei Sohara, Tatsuhiko Anzai, Kunihiko Takahashi, et al.

    Background: While greater protein intake may contribute to BUN levels in patients with CKD, few studies have investigated whether dietary fiber modifies the association. We aimed to examine the effect modification of the association between protein intake and BUN by dietary fiber in patients with non-dialysis-dependent CKD. Methods: We included 274 patients (median age 72 years; 34% women) at three hospitals in Japan. Food group and nutrient intakes were estimated using a validated diet history questionnaire. We compared food group intake by dietary fiber tertiles. Multiple linear regression assessed the association between protein intake and BUN, adjusting for potential confounders. We performed stratified analyses by dietary fiber tertiles and interaction analyses. Results: The median (interquartile range) BUN was 24 (19–37) mg/dL, and the mean (standard deviation (SD)) estimated glomerular filtration rate was 33 (16) mL/min/1.73m 2 . The mean (SD) protein and fiber intakes were 39 (8) and 6.5 (2.2) g/1000 kcal/day, respectively. Patients with higher fiber intake had greater intake of fruits, vegetables, fish, and eggs than those with lower fiber intake. Protein intake was positively associated with natural log-transformed BUN (regression coefficient (β) = 0.05, 95% CI: 0.01 to 0.08, for one SD increase in protein intake). The association appeared stronger in the low-fiber (β = 0.08, 95% CI: 0.02 to 0.14) and medium-fiber groups (β = 0.08, 95% CI: 0.02 to 0.13), whereas it was not significant in the high-fiber group (β = 0.01, 95% CI: -0.03 to 0.06) (P for interaction = 0.10). Conclusions: The positive association between protein intake and BUN was attenuated in patients with high fiber intake, who had higher intakes of fruits, vegetables, fish, and eggs. Further studies are warranted to examine whether more liberal protein restriction is feasible in BUN management by increasing dietary fiber.

  • Open Access

    Reversible Aphasia and Hemiparesis Caused by Intracranial Venous Reflux in a Patient on Hemodialysis With Central Venous Occlusion

    by Ayaka Suzuki, Takayasu Mori, Taisuke Kawasaki, Shota Aki, Suguru Hirasawa, Megumi Otani, Masato Sasaki, Kazuhiro Okai, Suzu Yoshida, Akiko Nagatomo, et al.

  • Open Access

    LRBA organizes distinct vesicular trafficking systems in distal nephron segments for water and sodium conservation

    by Kanako Nagaoka, Fumiaki Ando, Tamami Fujiki, Hassan Abolhassani, Yu Hara, Hideki Yanagawa, Soichiro Suzuki, Yuriko Sakamaki, Daisuke Oikawa, Hiroaki Kikuchi, et al.

    Lipopolysaccharide-responsive and beige-like anchor protein (LRBA) deficiency is a rare genetic disorder characterized by immune dysregulation. The immune checkpoint molecule cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) fails to perform proper membrane trafficking in the absence of LRBA. In addition to immune cells, LRBA localizes to intracellular vesicles in various epithelial cells; however, its physiological roles have not been accurately deciphered. It was observed in this study that LRBA facilitates water and sodium transport by promoting vesicular trafficking of aquaporin-2 (AQP2) and AQP4 in renal collecting duct cells and that of sterile 20/SPS1-related proline/alanine-rich kinase (SPAK) in distal convoluted tubule cells. Consequently, Lrba knockout mice exhibited vasopressin-resistant polyuria and hypotension under sodium-restricted conditions. This registry study revealed a polyuric phenotype in a subset of patients with LRBA deficiency, characterized by inappropriately low urine specific gravity despite the presence of chronic diarrhea. Notably, desmopressin treatment ameliorated impaired urinary concentration in a mouse model of human LRBA deficiency. LRBA functions as a central coordinator of fluid and sodium homeostasis by organizing segment-specific vesicular trafficking systems in renal epithelial cells.

  • Top Cited Papers
    Open Access

    Circulating Extracellular Vesicle MicroRNAs as Predictive Biomarkers for Kidney and Cardiovascular Events

    by Shunsuke Inaba, Takanori Hasegawa, Yuta Nakano, Shotaro Naito, Rena Suzukawa, Takaaki Koide, Hisateru Sekiya, Hisazumi Matsuki, Tamami Fujiki, Hiroaki Kikuchi, et al.

    Background: Chronic kidney disease ( CKD ) leads to premature mortality from cardiovascular events before kidney replacement therapy. Despite recognition of syndromes like cardiorenal anemia and cardiovascular‐kidney‐metabolic, predictive models for kidney and cardiovascular outcomes remain inadequate. This study aimed to develop a minimally invasive, risk model using circulating small extracellular vesicle‐derived mi RNAs among patients with CKD . Methods: A derivation cohort (n=36) underwent microarray‐based miRNA profiling, and a least absolute shrinkage and selection operator‐penalized Cox proportional hazards model was constructed. Validation was performed using TaqMan quantitative polymerase chain reaction in a cohort of 234 patients with CKD without kidney replacement therapy. The primary outcome was a ≥30% reduction in estimated glomerular filtration rate or progression to kidney replacement therapy. The secondary outcome included all‐cause mortality, kidney replacement therapy initiation, and major adverse cardiovascular events. Results: In the derivation cohort, 36% of patients had hypertensive glomerulosclerosis as the underlying CKD cause, increasing to 48% in the validation cohort. Twenty‐three miRNAs were significantly downregulated in advanced CKD , associated with cellular senescence, FOXO (forkhead box, class O) signaling, and cell cycle pathways. From these, 3 miRNAs — hsa‐let‐7d‐5p , hsa‐ miR ‐24‐3p , and hsa‐ miR ‐126‐3p —were selected and integrated into the final risk score with cystatin C and urinary protein levels, following optimization in the validation cohort. Lower miRNA levels were linked to cardiovascular comorbidities and cardiorenal anemia syndrome. Over a median follow‐up of 39 and 59 months, 108 kidney events and 70 composite outcomes occurred. The model effectively predicted adverse outcomes across CKD causes, further stratifying risk within cardiovascular‐kidney‐metabolic stage classifications. Conclusions: Circulating small extracellular vesicle‐derived miRNA profiles enable a noninvasive, longitudinally predictive model for adverse kidney and cardiovascular outcomes in CKD . This approach may improve early risk identification and clinical decision‐making.


  • Open Access

    Association between serum bicarbonate and low mid‐upper arm circumference in patients with non‐dialysis‐dependent chronic kidney disease: A cross‐sectional study

    by Nobuhisa Morimoto, Shintaro Mandai, Tamami Fujiki, Fumiaki Ando, Takayasu Mori, Koichiro Susa, Shotaro Naito, Eisei Sohara, Tatsuhiko Anzai, Kunihiko Takahashi, et al.

    Background: Although previous experimental studies showed that metabolic acidosis promoted muscle catabolism and impaired protein synthesis, few epidemiological studies reported an independent association between serum bicarbonate levels and muscle atrophy in patients with chronic kidney disease (CKD). We examined the association between serum bicarbonate levels and low mid‐upper arm circumference (MUAC), a surrogate marker of low muscle mass, in older adults with non‐dialysis‐dependent CKD. Methods: A total of 174 patients aged ≥65 years with an estimated glomerular filtration rate 2 (33.9% women) were eligible. We cross‐sectionally examined the association between serum bicarbonate levels and MUAC using multiple linear regression, adjusting for potential confounders selected by a directed acyclic graph of our causal model. The association between serum bicarbonate and low MUAC was examined by multiple Poisson regression with robust variance. We used two cutoffs to define low serum bicarbonate: serum bicarbonate levels P = 0.019). Serum bicarbonate levels P = 0.002), whereas the association was attenuated for serum bicarbonate levels <22 mmol/L. Restricted cubic spline analyses suggested a nonlinear association between serum bicarbonate levels and low MUAC. Conclusion: We found an independent association between serum bicarbonate levels <24 mmol/L and low MUAC, calling for further prospective studies to elucidate the target serum bicarbonate level that would help retard muscle atrophy.

  • Open Access

    Importance of family history and health checkup for school-aged children for type IV collagen-associated nephropathy in hereditary kidney disease

    by Ryosuke Kawamoto, Takayasu Mori, Motoko Chiga, Takuya Fujimaru, Azuma Nanamatsu, Tamami Fujiki, Yutaro Mori, Shintaro Mandai, Fumiaki Ando, Koichiro Susa, et al.

    Background: Advancements in genetic analysis have revealed a higher prevalence of hereditary kidney disease than expected. This study focuses on the enrollment and analysis of patients with chronic kidney disease (CKD) and a family history of CKD to identify disease-causing variants. Additionally, by incorporating data from childhood urine tests, the study examines the utility of these screenings in early disease detection. Methods: An observational study utilizing genetic data and clinical assessments from patients with familial CKD. A total of 85 patients with familial CKD, diagnosed by clinicians and confirmed through genetic testing from 2014 to 2020, were included. Patients with cystic kidney diseases were excluded. The presence of COL4As ( COL4A3 , COL4A4 , COL4A5 ) gene variants and other genetic variants associated with kidney disease was examined using a comprehensive gene panel. Results: Of the patients, 41.2% had disease-causing variants in COL4As variants. The median age at manifestation onset was significantly lower in the COL4As group compared to patients with other disease-causing variants or those with no identified disease-causing variants. Early manifestations of microscopic hematuria were notably prevalent, indicating potential early markers for genetic kidney diseases. Conclusions: The findings underscore the importance of family history in diagnosing genetic kidney diseases and suggest that early genetic testing, coupled with regular monitoring of urinary abnormalities, could significantly improve disease management and outcomes. Further research is necessary to explore comprehensive genetic screening and its integration into routine clinical practice. Graphical


  • Author's Reply: “Associations Between Dietary Potassium Intake From Different Food Sources and Hyperkalemia in Patients With Chronic Kidney Disease”

    by Nobuhisa Morimoto, Shingo Shioji, Yuichiro Akagi, Tamami Fujiki, Shintaro Mandai, Fumiaki Ando, Takayasu Mori, Koichiro Susa, Shotaro Naito, Eisei Sohara, et al.

  • Open Access

    A parent and child with Liddle syndrome diagnosed correctly with the child as the proband: a case report with review of literature

    by Minako Tokunaga, Yuko Seki, Tatsushi Horiguchi, Kiwako Miura, Haruna Kakimoto, Satoshi Morita, Michiyo Mizota, Koshi Kusumoto, Takayasu Mori, Eisei Sohara, et al.

    Liddle syndrome (LS) is an autosomal dominant genetic disorder characterized by early onset hypertension, hypokalemia, and low plasma aldosterone or renin concentration. It is caused by mutations in subunits of the epithelial sodium channel (ENaC). The clinical phenotypes of LS are variable and nonspecific, making it prone to both misdiagnosis and missed diagnosis. Genetic analysis is necessary to confirm the diagnosis of LS. Herein, we report the case of a 42-year-old male with LS and a 30-year history of hypertension. He was being treated for possible primary aldosteronism (PA) over the preceding 7 years; however, his hypertension was poorly controlled despite intensive combination therapy. His 13-year-old son served as a proband for a diagnosis of LS, as he had hypertension, hypokalemia, and a significant family history of hypertension. Genetic testing revealed a heterozygous pathological variant in the SCNN1B gene. This led to a diagnosis of LS, as the father was found to harbor the same mutation. Both were treated with ENaC inhibitors and a salt-restricted diet, which improved their symptoms markedly. The son’s genetic diagnosis facilitated the subsequent proper diagnosis and treatment of his father. LS causes early onset hypertension; hence, its early diagnosis and treatment can prevent complications. Hereditary hypertension should be considered in cases of early onset hypertension with a significant family history. Patients diagnosed with PA using outdated criteria may have concomitant LS and require careful evaluation of biochemical and endocrine tests according to the current criteria.


  • Open Access

    ULK1-regulated AMP sensing by AMPK and its application for the treatment of chronic kidney disease

    by Tomoki Yanagi, Hiroaki Kikuchi, Koh Takeuchi, Koichiro Susa, Takayasu Mori, Motoko Chiga, Kouhei Yamamoto, Asuka Furukawa, Takumi Kanazawa, Yuki Kato, et al.


  • Open Access

    Adult renal tubular organoids can be produced from different human individuals in a completely same protocol

    by Makiko Mori, Yutaro Mori, Nakao Yuki, Shintaro Mandai, Tamami Fujiki, Hiroaki Kikuchi, Fumiaki Ando, Koichiro Susa, Takayasu Mori, Yuma Waseda, et al.

    Introduction Organoids are miniature organs produced by newly emerging technologies. Kidney organoids originated from human inducible pluripotent stem cells (iPSCs) were developed to recapitulate renal diseases. However, producing iPSC kidney organoids from multiple individuals at the same time and in a uniform condition is still impossible. Here, we report adult renal tubular organoids, “tubuloids”, established from primary renal epithelial cells from multiple human individuals in a uniform manner. Methods Kidneys obtained from patients due to the surgery for malignancy were minced into small pieces, and primary renal epithelial tubule cells are cultured. 4 patients had normal kidney function and 4 had mild chronic kidney disease (CKD). Growth factors were added to the primary cultured cells at the same time and Matrigel was added to these 8 lines. Results Primary cultured renal epithelial cells from normal kidneys showed a large number of fine, swollen epithelial appearance. On the other hand, primary cultured kidney epithelial cells from mild CKD kidneys were smaller and slightly elongated than those of normal kidneys. The growth speed was faster in normal kidney cells than in mild CKD cells. At the beginning of the three-dimensionalization (day 0), normal renal tubuloids grew faster than mild CKD tubuloids. The difference in size between normal tubuloids and mild CKD ones became less noticeable on day 5. Both types of tubuloids reached almost same size on day 10. All 8 strains are of different human origin, and uniform tubuloids could be produced at the same time and in a uniform protocol. Conclusion In terms of pathological models, the differences between mouse models and humans cannot be ignored, and there is a great need for a more human-like model of human pathology from both medical and research perspectives. Our renal tubular organoids can be produced in a uniform manner at the same time. It is expected to be used as a new type of convenient human pathological model.